Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Neuropathol Appl Neurobiol. 2010 Dec;36(7):661–672. doi: 10.1111/j.1365-2990.2010.01101.x

Table 2. Characteristics of LOD patients and controls.

LOD
N (%)		 Controls
N (%)
N 38 29
Age, years (SD) 79 (6.1) 80 (8.6)
Male gender (%) 16 (42) 15 (52)
Braak stage I for NFT [47] 25 (65.8) 13 (44.8)
Braak stage II for NFT [47] 12 (31.6) 15 (51.7)
Braak stage III for NFT [47] 1 (2.6) 1 (3.5)
Phase 1 for SP [48] 17 (44.7) 19 (65.5)
Phase 2 for SP [48] 12 (31.6) 7 (24.1)
Phase 3 for SP [48] 3 (7.9) 3 (10.4)
Phase 4 for SP [48] 6 (15.8) 0 (0)
Hypertension (%) 12 (32) 14 (48)
Diabetes (%) 6 (16) 7 (24)
Smoking (%) 5 (13) 2 (7)

NFT = neurofibrillary tangles; SP = senile plaques.